European Union and EDCTP strategy in the global context: Recommendations for preventive HIV/AIDS vaccines research

The European Commission (EC) has strong commitments and recognises the need to continue to ensure that HIV/AIDS research efforts receive global attention. The EC is facing this challenge in a global context and has made substantial investments together with European Developing Countries Clinical Tri...

Full description

Saved in:

Bibliographic Details
Published in:	Vaccine Vol. 23; no. 48; pp. 5551 - 5556
Main Authors:	Lehner, Thomas, Hoelscher, Michael, Clerici, Mario, Gotch, Frances, Pedneault, Louise, Tartaglia, Jim, Gray, Clive, Mestecky, Jiri, Sattentau, Quentin, Wijgert, Janneke van de, Toure, Coumba, Osmanov, Saladin, Schmidt, Reinold E., Debre, Patrice, Romaris, Manuel, Hoeveler, Arnd, Di Fabio, Simonetta
Format:	Journal Article
Language:	English
Published:	Oxford Elsevier Ltd 01-12-2005 Elsevier Elsevier Limited
Subjects:	Acquired immune deficiency syndrome Acquired Immunodeficiency Syndrome - prevention & control AIDS AIDS Vaccines - administration & dosage AIDS Vaccines - adverse effects AIDS Vaccines - standards Applied microbiology Biological and medical sciences Candidates Clinical trials Clinical Trials as Topic Developing Countries Drug resistance Epidemiology European Commission Strategy European Union Fundamental and applied biological sciences. Psychology Health Planning Guidelines HIV HIV - growth & development HIV - immunology HIV/AIDS Human immunodeficiency virus Human viral diseases Humans Immunology Infections Infectious diseases Infrastructure Laboratories LDCs Medical sciences Microbiology Miscellaneous Population Retention Safety Studies Vaccine Vaccines Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids Viral infections Virology East Asia Europe Africa HIV/AIDS Vaccine European Commission Strategy Infection Virus Immunopathology Viral disease Retroviridae AIDS Human immunodeficiency virus Immune deficiency Lentivirus
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The European Commission (EC) has strong commitments and recognises the need to continue to ensure that HIV/AIDS research efforts receive global attention. The EC is facing this challenge in a global context and has made substantial investments together with European Developing Countries Clinical Trial Partnership (EDCTP) to formulate a program for the accomplishment of a scientific strategic plan promoting the European/African HIV vaccine development approach. The EC and EDCTP has convened a number of meetings by experts in basic and clinical virology, immunology, epidemiology, as well as industrial and regulatory representatives. The remit of the committee of experts was to define (1) objective criteria for selection of HIV candidates; (2) to determine criteria for selection of sites for clinical trials in Europe and Africa. The resulting consensus paper will guide the EC and EDCTP in developing HIV vaccine strategy and recommendations.
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2
ISSN:	0264-410X 1873-2518
DOI:	10.1016/j.vaccine.2005.07.009